Interestingly, we reached the same conclusion as in the meta-analysis: SMAD4 expression was lower in NSCLC than in normal lung tissue, and good OS was observed in NSCLC patients with higher SMAD4 expression. The gene discussed is SMAD4; the disease is non-small cell lung carcinoma.